Spacer
Cirrus Pharmaceuticals, Inc.
Spacer
 

Services

 

 
Overview
Formulation Development
Analytical Services
Characterization
Extractables & Leachables Services
Particle Size Analysis
Peptides and Proteins
Nanotechnology
Stability Testing
Device Evaluation
Process Development
Regulatory Submission
Manufacturing Oversight and Batch Release
   
info@cirruspharm.com

Device Testing and Device Selection Services from Cirrus

Several pharmaceutical and biotechnology products employ devices. Selection or development of an appropriate device is critical for overall product performance. Cirrus’ scientists have expertise with several types of devices including:

  • Nebulizer
  • Dry Powder Inhaler (DPI)
  • Metered Dose Inhaler (MDI)
  • Nasal Spray
  • Catheter
  • Stent

Device Testing Services

  • Product performance testing
  • Device-formulation compatibility testing
  • In-use stability testing
  • Extractables and Leachables testing
  • Simulated patient use studies

Product Performance Testing

  • Geometric particle size distribution by laser diffraction
  • Aerodynamic particle size distribution and respirable fraction by inertial impaction methods
  • Emitted dose
  • Output rate
  • Leakage rate
  • Tail-off characteristics
  • Cyr test
  • Drop test

Cirrus can design and conduct experiments for device performance testing and can recommend a suitable delivery device or assist in development of devices. The work can be conducted under GMP or GLP conditions to be included in a regulatory submission. Furthermore, our senior staff, who have many years of industry experience both with device development and regulatory filing, can provide support with the device regulatory submission.